DRIP1 Polyclonal Antibody, Cy5.5 Conjugated
Product Specifications
Background
1.C14ORF28, GNB2L1, MLLT3, DRD2 and DARPP-32 are important in the pathogenesis of schizophrenia and bipolar disorder; 2. these two disorders share common disease-related mechanisms linked to dopamine signalling; 3. the expression of these genes is closely correlated; and 4. DRD2 provides the initial trigger in the pathogenesis of these disorders.
Synonyms
CN028_HUMAN; Dopamine receptor interacting protein 1; Dopamine receptor-interacting protein 1; DRIP 1; DRIP1; Uncharacterized protein C14orf28; C14orf28.
Gene ID
122525
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Immunogen
31-130/310
Target
DRIP1
Clonality
Polyclonal
Isotype
IgG
Conjugation
Cy5.5
Source
KLH conjugated synthetic peptide derived from human DRIP1/C14orf28
Applications
WB, IF (IHC-P)
Purification
Purified by Protein A.
Excitation Emission
675nm/694nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), IF (IHC-P) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
122525
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS5824980 Inquire
4,5-Dihydroxy-2- ((5-methyl-3,8-dimethylene-2-oxododecahydroazuleno[6,5-b]furan-5-yl) oxy) tetrahydro-2H-pyran-3-yl acetate
Ask
View Details 